Table 2 Contribution of causative genes

From: Clinical and genetic landscape of IRD in Portugal: pooled data from the nationwide IRD-PT registry

Gene(s)

Number of cases of solved cohort (%)

Gene(s)

Number of families of solved cohort (%)

ABCA4

124 (12.0%)

ABCA4

106 (13.0%)

EYS

95 (9.2%)

  

RPGR

76 (7.3%)

EYS

81 (10.0%)

USH2A

64 (6.2%)

USH2A

56 (6.9%)

RHO

41 (4.0%)

  

RS1, PRPH2

27 (2.6%) per gene

RPGR

30 (3.7%)

RPE65

26 (2.5%)

RHO

27 (3.3%)

ABCC6, BEST1

25 (2.4%) per gene

RS1

21 (2.6%)

MYO7A

21 (2.0%)

RPE65, ABCC6

20 (2.5%) per gene

BBS1

17 (1.6%)

MYO7A, PRPH2

17 (2.1%) per gene

PRPF31

16 (1.5%)

BEST1

16 (2.0%) per gene

PAX6

15 (1.4%)

BBS1

15 (1.8%) per gene

PROM1, NR2E3, CNGB1

12 (1.2%) per gene

PRPF31

13 (1.6%)

KCNV2, IMPG2, MT-TL1, RDH5

11 (1.1%) per gene

KCNV2

11 (1.4%)

VCAN, CERKL, PDE6A, CRB1, CNGB3

10 (1.0%) per gene

PROM1, NR2E3, CERKL, CRB1, CNGB1

10 (1.2%) per gene

LRAT, ADGRV1, TYR

9 (0.9%) per gene

PAX6, ADGRV1, PDE6A, RDH5

9 (1.1%) per gene

CHM, RDH12, MERTK

8 (0.8%) per gene

TYR, CNGB3, MT-TL1

8 (1.0%) per gene

CEP290, CNGA3, RPGRIP1, COL2A1

7 (0.7%) per gene

VCAN, CEP290, RDH12, RPGRIP1

7 (0.9%) per gene

PDE6B, BBS10, IMPDH1

6 (0.6%) per gene

IMPG2, MERTK, CNGA3

6 (0.7%) per gene

CACNA1F, NMNAT1, PRPF8, SDCCAG8, RP1, RP2, PCARE, C1QTNF5, MT-ATP6, BBS2

5 (0.5%) per gene

NMNAT1, PRPF8, SDCCAG8, RP1

5 (0.6%) per gene

HGSNAT, IMPG1, OAT, CDH3, COL4A5, PANK2, ARSG, NA

4 (0.4%) per gene

PDE6B, IMPG1, CACNA1F, LRAT, CDH3, COL4A5, PANK2, BBS10, RP2, PCARE, IMPDH1, COL2A1, BBS2, NA

4 (0.5%) per gene

BBS12, RLBP1, ATXN7, MKKS, ABHD12, GRK1, SPATA7, GUCY2D, TTLL5, WDR19, MFRP, COL18A1, CRX, CDH23, MITF

3 (0.3%) per gene

HGSNAT, BBS12, OAT, RLBP1, CHM, ARSG, SPATA7, GUCY2D, WDR19, MFRP, MT-ATP6, COL18A1, CDH23

3 (0.4%) per gene

NPHP1, SLC38A8, TOPORS, AIPL1, VPS13B, PDE6C, TRPM1, CYP4V2, CEP250, PEX1, PYGM, CDH7, CNNM4, KIZ, ALMS1, PISD, NPHP4, OCA2, RAB28

2 (0.2%) per gene

SLC38A8, TOPORS, AIPL1, VPS13B, PDE6C, TRPM1, CYP4V2, ATXN7, ABHD12, CEP250, TTLL5, PYGM, C1QTNF5, CHD7, CRX, CNNM4, MITF, ALMS1, OCA2

2 (0.2%) per gene

ATF6, DNAJC21, GPATCH11, AHI1, DMPK, BBS4, RP1L1, USH1G, CPLANE1, POC1B, HPS6, TTC8, SAG, PAX2, LCA5, IFT140, COL11A1, GPR143, KLHL7, HADHA, PMM2, COL4A3, SLC19A2, PRPF3, MMACHC, COL4A4, ADAM9, CACNA2D4, KIF11, LYST, CNGA1, CDHR1, IDS, TRAF3IP1, SLC24A1, TTPA, TIMP3, OTX2, IQCB1, ARL2BP, SCAPER, PDZD7, RBP4, PPT1, BBS7, IFT122

1 (0.1%) per gene

NPHP1, ATF6, DNAJC21, GPATCH11, AHI1, DMPK, BBS4, RP1L1, USH1G, CPLANE1, POC1B, HPS6, MKKS, TTC8, GRK1, SAG, PAX2, PEX1, LCA5, IFT140, COL11A1, GPR143, KLHL7, HADHA, PMM2, COL4A3, SLC19A2, PRPF3, MMACHC, COL4A4, ADAM9, CACNA2D4, KIF11, LYST, CNGA1, CDHR1, IDS, KIZ, TRAF3IP1, PISD, SLC24A1, TTPA, TIMP3, OTX2, IQCB1, ARL2BP, SCAPER, PDZD7, RBP4, PPT1, NPHP4, BBS7, IFT122, RAB28

1 (0.1%) per gene

  1. NA not applicable cases due to complexity (n = 4 individuals from 4 families).